- Fee assured
- Verified this account
- Inflammatory bowel disease
Dr Prakash Gupta qualified in 2003 from The Royal Free and University College Medical School where he trained as a junior house officer. Following this he subsequently went on to complete his Membership of the Royal College of Physicians and then began registrar training in Gastroenterology and Hepatology in the Oxford Deanery.
During his time at The Oxford Deanery Dr Gupta completed advanced hepatology training and gained liver transplant experience at Addenbrooke’s Hospital in Cambridge. He also completed his Doctor of Philosophy qualification from Oxford University on HCV immunology and genomics whilst a research fellow at Harvard Medical School in Boston, USA, for 3 years.
After completing triple accreditation CCT in Medicine, Gastroenterology and Hepatology Dr Gupta was appointed a locum consultant at the John Radcliffe Hospital in Oxford before taking up a substantive post at Milton Keynes University Hospital. At Milton Keynes Dr Gupta holds a number of pivotal roles including, Lead in Hepatology, Clinical Governance for Gastroenterology and he is also the Consultant BMA representative and Local Negotiating Committee Chair.
On top of his consultancy work Dr Gupta also provides regular lectures and teaching to junior doctors and medical students in Buckingham and Oxford. He maintains close ties with Oxford University Hospitals, having set up a local Hepatitis B and C service with them, and also maintains close links with Cambridge University Hospitals having set up a joint liver transplant clinic.
Dr Gupta is also proficient in upper GI endoscopy and colonoscopy and a certified trainer.
Areas of interest
Gastro-oesophageal reflux disease (GORD); Dyspepsia; Gastritis; Abdominal pain; Vomiting; Dysphagia; Difficulty swallowing; Gallstones; Liver Disease; Fatty Liver; Hepatitis; Diarrhoea; Constipation; Diverticular Disease; Food intolerance; Food Allergy; Irritable bowel Syndrome; Rectal Bleeding; Inflammatory Bowel Disease; Crohn's Disease; Ulcerative colitis; Gastroscopy; Colonoscopy; Endoscopy;
- Avril Jacquest
- BMI Saxon Clinic Chadwick Drive Eaglestone West Milton Keynes MK6 5LR
- 01908 997107
- 07870 267688
- 01908 997764
Anaesthetists worked with
- Dr Akol Sarah Aturia Fee Assured
Current NHS consultant posts held
Milton Keynes University hospital (Substantive)
Standing Way, Eaglestone,
Oxford University Hospitals (Honorary)
John Radcliffe Hospital
Headley Way, Headington,
Liver Disease and General Gastroenterology. Have published in various areas of Gastroenterology including liver/hepatobiliary disease, viral hepatitis, liver immunology and genomics, upper gastrointestinal disease and nutrition.
Travel, Fitness, Family, Economics.
Wellcome Trust Research Training Fellowship
Norah Schuster Essay Prize
Use of genome wide expression profiles in analysis of CD8 T cell dysfunction in Hepatitis C virus infection. Oxford University. Department of Clinical Medicine. 2015.
CD39 expression identifies terminally exhausted CD8+ T cells. PLOS Pathogens. 2015 Oct.
Hepatitis C virus: current concepts and future challenges. QJM. 2011 Nov;105(1):29-32.
Efficacy of nasal bridles in avoiding percutaneous endoscopic gastrostomy placement. Frontline Gastroenterol. 2012;3:109-111
Biloma: An unusual complication in a patient with pancreatic cancer. World Journal of Gastroenterology. 2009 Nov 7;15 (41):5218-5220
An unusual cause of dyspepsia: oesophageal vavernous haemangioma. QJM.2010 March 10.1093
Risk Modification in patients with Peripheral Arterial Disease:a retrospective Study. Angiology. 2005 May-June;56(3):279-287.
The Effect of Short-Term Treatment with Simvastatin on Renal Function in Patients with Peripheral Arterial Disease. Angiology. 2004 Jan-Feb;55(1):53-62.
Identification of novel, biologically distinct T cell responses to chronic viral infection by unsupervised analysis of gene expression profiles of hepatitis C-specific CD8+ T cells. J Immunol 2012 188:105.12
Metagene projection strategies for discovering mechanisms of T cell differentiation in gene expression profiling data. J Immunol 2012 188:58.13
Efficacy of nasal bridles in preventing nasogastric tube displacement. The Royal Berkshire experience. BSG & DDW 2010
Chandra N, Hodgkiss C, Gupta P, Mee A. Do patients presenting with obstructive symptoms, abnormal LFT’s and gallstones on USS require an MRCP before ERCP? BSG & DDW 2010
The role of a trained respiratory physician in lung cancer management. European Respiratory Society Annual Congress 2008.
A case of bronchial anthracofibrosis. European Respiratory Society Annual Congress 2008.
The History of Amputation and Prosthetic Limb Development.
Presented at the Royal Society of Medicine (2002)
In Vitro Testing of Porous Hydroxyapatite as a Drug Delivery System for methetrexate with Potential Application in the Local Treatment of Osteogenic Sarcoma. Royal National Orthopaedic Hospital, Institute of Orthopaedics, Department of Musculo-skeletal Science, University College London, Brockley Hill, Stanmore.
Courses offered to GPs
Investigation of abnormal liver function tests and Non-Alcoholic Fatty Liver Disease.
- BSc University College London 2001
- MB BS University College London 2003
- MRCP (London) Royal College of Physicians 2008
- DPHil University of Oxford 2014
- Liver Transplant Fellowship Cambridge University Hospitals 2014
- Harvard Research Fellow Harvard Medical School 2010
Reference number 6077416
Professional bodies (positions held - last 3 yrs)
- MRCP Gastroenterology Royal College of Physicians 2016
- EASL EASL 2018
- British Society of Gastroenterology BSG 2018
- Milton Keynes Hospital Consultant Representative British Medical Association 2018
Details of entry to specialist register
- Gastroenterology/Hepatology/General medicine, 2016
Affiliations / memberships
- Saxon StreetEaglestoneMILTON KEYNESMK6 5LR
- 08:30 - 12:00
- 01908 232142
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details